Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2002) 17: 51-54
© 2002 European Renal Association-European Dialysis and Transplant Association

SECTION IV: Dialysis fluid purity

IV.6 Dialysis fluid purity: implications in the haemocompatibility network system

Abstract

Over the last decade, microbiological contamination of the dialysis fluid has become a major concern [70–72]. In the early 1980s dialysis fluid purity was mainly targeted to prevent pyrogenic reactions associated with the use of bicarbonate buffer and back-transport phenomena (back-filtration, back-diffusion) of dialysis fluid to the blood [73]. From this perspective, the role of the dialyzer membrane is essential to prevent the blood passage of cytokine-inducing substances from dialysis fluid [74–77] and/or to prevent immunization against dialysis fluid endotoxin [78]. From the late 1990s the dialysis fluid purity was considered as one of the main factors in the complex haemocompatibility network [79–82].

UPD is a concept introduced in the mid 1990s that qualifies a sterile and non-pyrogenic dialysate produced extemporaneously by ‘cold sterilization’ by means of ultrafilters [83]. Over the last few years it has been recognized that dialysate purity should tend to ultrapure product for contemporary dialysis to prevent the potential hazards associated with contaminated dialysate [84–88].

Guideline IV.6.1

A. Regular use of UPD appears desirable in long-term haemodialysis patients to prevent and/or to delay the occurrence of dialysis related complications.

(Evidence level: B)


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.